Krystal Biotech to Present at the 43rd Annual TD Cowen Health Care Conference
March 02 2023 - 7:00AM
Krystal Biotech, Inc. (the “Company”) (NASDAQ: KRYS) a
biotechnology company focused on developing and commercializing
genetic medicines for patients with rare diseases, announced today
that the Company will participate in the 43rd Annual TD Cowen
Health Care Conference, which is taking place in Boston from March
6-8.
Krish S. Krishnan, Chairman and Chief Executive Officer, will
participate in a fireside chat during the conference and host
investor meetings on March 7 at 10:30am ET.
A webcast of the presentation will be available here, and an
archived version of the webcast will be available following the
presentation on the Investor section of the Company’s website.
About Krystal Biotech, Inc.
Krystal Biotech, Inc. (NASDAQ: KRYS) is a biotechnology company
focused on developing and commercializing genetic medicines for
patients with rare diseases. The Company’s wide-ranging pipeline is
based on its proprietary redosable HSV vector. Headquartered in
Pittsburgh, Pennsylvania, the Company is led by an experienced
management team, is fully-integrated and has core capabilities in
viral vector design, vector optimization, gene therapy
manufacturing and commercialization. For more information, please
visit http://www.krystalbio.com, and follow @KrystalBiotech on
LinkedIn and Twitter.
CONTACT:
Investors and Media
Meg DodgeKrystal
Biotechmdodge@krystalbio.com
Krystal Biotech (NASDAQ:KRYS)
Historical Stock Chart
From Jul 2024 to Aug 2024
Krystal Biotech (NASDAQ:KRYS)
Historical Stock Chart
From Aug 2023 to Aug 2024